tirzepatide optic neuropathy GLP-1 medicine and non-arteritic anterior ischemic neuropathy: Literature review and perspectives Glaucomatous Optic Neuropathy & Latest
Description
There is no evidence that any particular protein source interferes with tirzepatide's mechanism of action

Gualtieri CT, Morgan DW
Most providers consider any variance under 5% to be clinically insignificant

Comparing the two brand-name options
doi: 10.1007/s12247-020-09460-2
Quick Answer: Tirzepatide requires following prescribed dose escalation, weekly injection schedules, and site rotation while avoiding use in patients with personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
